Total Funding
12
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
CanDiag develops and commercializes diagnostic blood tests designed to detect breast cancers.
Rahul Puri: Co-Founder
Pinku Mukherjee: Co-Founder, CEO & Chief Scientific OfficerPast Role: Mayo Clinic, Team Member
About the Company
CanDiag, Inc. is a University of North Carolina Charlotte (UNCC) spin-off that was incorporated in November 2010. Dr. Pinku Mukherjee, Irwin Belk Endowed Professor for Cancer Research at UNCC, is the founder of CanDiag. They have a worldwide exclusive license to a patented tumor antibody that has been used to develop a blood test for the early
detection of breast cancer. Their vision is to expand their capabilities and offer services and products ranging from accurate cancer screening kits to targeted drug delivery systems for cancers that affect men and women.
Women Founded
